| 000 | 01901 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250514020316.0 | ||
| 264 | 0 | _c20020122 | |
| 008 | 200201s 0 0 eng d | ||
| 022 | _a0027-8424 | ||
| 024 | 7 |
_a10.1073/pnas.261568398 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDybul, M | |
| 245 | 0 | 0 |
_aShort-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters. _h[electronic resource] |
| 260 |
_bProceedings of the National Academy of Sciences of the United States of America _cDec 2001 |
||
| 300 |
_a15161-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadverse effects |
| 650 | 0 | 4 |
_aAntiretroviral Therapy, Highly Active _xadverse effects |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymph Nodes _xpathology |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aRNA, Viral |
| 700 | 1 | _aChun, T W | |
| 700 | 1 | _aYoder, C | |
| 700 | 1 | _aHidalgo, B | |
| 700 | 1 | _aBelson, M | |
| 700 | 1 | _aHertogs, K | |
| 700 | 1 | _aLarder, B | |
| 700 | 1 | _aDewar, R L | |
| 700 | 1 | _aFox, C H | |
| 700 | 1 | _aHallahan, C W | |
| 700 | 1 | _aJustement, J S | |
| 700 | 1 | _aMigueles, S A | |
| 700 | 1 | _aMetcalf, J A | |
| 700 | 1 | _aDavey, R T | |
| 700 | 1 | _aDaucher, M | |
| 700 | 1 | _aPandya, P | |
| 700 | 1 | _aBaseler, M | |
| 700 | 1 | _aWard, D J | |
| 700 | 1 | _aFauci, A S | |
| 773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 98 _gno. 26 _gp. 15161-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.261568398 _zAvailable from publisher's website |
| 999 |
_c11648210 _d11648210 |
||